11-12 September 2018 //  Lancaster Royal Hotel, London


Sharron Gargosky

Dr Sharron Gargosky

Chief Clinical and Regulatory Officer , OnoSec Medical Incorporated

Dr. Gargosky has over 20 years of experience in clinical development and operations in the field of pharmaceutical and biologic development having managed global programs from early research phase through the U.S. Food & Drug Administration (FDA) approval process. She has been involve din FDA orphan drug approvals and is extensively published. Currently, Dr. Gargosky is the Chief Clinical and Regulatory Officer at OncoSec Medical Incorporated where she manages the immune-oncology program in metastatic melanoma and other pipeline programs, including the CMC, non clinical, clinical programs. Prior to that she was the Chief Technical and Operations Officer at Prima Biomed, Ltd., where she led the immuno-oncology program in ovarian and pancreatic cancer globally and throughout her career has served in positions of increasing clinical and scientific responsibility at biopharmaceutical companies including Pharmacia, Medicis, and Hyperion Therapeutics. Dr. Gargosky received her Ph.D. from the University of Adelaide, Australia and completed her postdoctoral fellowship at Stanford University.


2017 Speakers

"It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance."

Bertrand Alexandre, Director, Marketing Europe, Celyad